<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Amyloid β and alpha 1-antichymotrypsin (ACT) play an important role in the pathogenesis of <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) </plain></SENT>
<SENT sid="1" pm="."><plain>The present study was to investigate whether a combination of plasma biomarkers and clinical data would discriminate AD from vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, other neurodegenerative <z:hpo ids='HP_0000726'>dementia</z:hpo> and non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> controls </plain></SENT>
<SENT sid="2" pm="."><plain>The study included 112 patients with AD, 85 patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, 30 patients with other neurodegenerative <z:hpo ids='HP_0000726'>dementia</z:hpo> and 116 age-matched, non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> controls </plain></SENT>
<SENT sid="3" pm="."><plain>Although ACT, Aβ42 and the ratio of Aβ42/Aβ40 had significant differences between AD, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, other neurodegenerative <z:hpo ids='HP_0000726'>dementia</z:hpo> and non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> controls (P&lt;0.001), none of them reached the sensitivity and specificity required for AD biomarkers </plain></SENT>
<SENT sid="4" pm="."><plain>The combination of biomarkers and clinical data had higher discriminating power than either alone </plain></SENT>
<SENT sid="5" pm="."><plain>Our results indicated that plasma biomarkers of ACT and the ratio of Aβ42/Aβ40 could discriminate AD from non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> controls, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, or other neurodegenerative <z:hpo ids='HP_0000726'>dementias</z:hpo> with higher diagnostic accuracy than clinical data and that if plasma biomarkers were combined with clinical data, the discriminating power was enhanced </plain></SENT>
</text></document>